BioCardia Executives Increase Their Stakes in the Company
BioCardia has seen significant insider purchases recently, as reported in SEC Form 4 filings. President and CEO Peter Altman acquired 26,246 shares of common stock at $1.905 each, investing a total of $49,998. This transaction increases his direct ownership to 138,966 shares.
Bill Facteau, a Director at BioCardia, purchased 13,123 shares at the same price of $1.905 per share, amounting to a $24,999 investment, bringing his direct ownership to 13,123 shares.
Chief Financial Officer David McClung also participated, buying 13,123 shares at $1.905 each for a total of $24,999, which increased his direct stake to 43,131 shares.
Reporter Name
Relationship
Type
Amount
SEC Filing
Altman Peter
President and CEO
Purchase
$49,998
Form 4
Facteau Bill
Director
Purchase
$24,999
Form 4
Mcclung David
Chief Financial Officer
Purchase
$24,999
Form 4